Export this record

Export record to excel

File type to download

Beta version

Select record 1

ArticlesPeer ReviewedFull Text

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

Author / Creator:Topp, Max S, Dr ; Gökbuget, Nicola, MD ; Stein, Anthony S, MD ; Zugmaier, Gerhard, MD ; O'Brien, Susan, MD ; Bargou, Ralf C, Prof ; Dombret, Hervé, MD ; Fielding, Adele K, PhD ; Heffner, Leonard, MD ; Larson, Richard A, Prof ; Neumann, Svenja, MD ; Foà, Robin, MD ; Litzow, Mark, Prof ; Ribera, Josep-Maria, Prof ; Rambaldi, Alessandro, MD ; Schiller, Gary, MD ; Brüggemann, Monika, MD ; Horst, Heinz A, MD ; Holland, Chris, MS ; Jia, Catherine, PhD ; Maniar, Tapan, MD ; Huber, Birgit, PhD ; Nagorsen, Dirk, MD ; Forman, Stephen J, MD ; Kantarjian, Hagop M, Prof

Publisher:England: Elsevier Ltd

Journal title:The lancet oncology, 2015-01, Vol.16 (1), p.57-66

View online as a Library member

Export record to excel

Export this record

Export record to excel

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

Export this record

Export record to excel

Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

Refine your search

Search the collection

Export record to excel

Export this record

Export record to excel

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

Export this record

Export record to excel

Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

Refine your search